DEL GAUDIO, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 6.367
EU - Europa 4.235
AS - Asia 2.351
AF - Africa 429
SA - Sud America 13
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.404
Nazione #
US - Stati Uniti d'America 6.347
GB - Regno Unito 1.116
CN - Cina 806
IT - Italia 717
SE - Svezia 672
SG - Singapore 629
DE - Germania 535
VN - Vietnam 526
IN - India 261
UA - Ucraina 243
IE - Irlanda 216
RU - Federazione Russa 174
FR - Francia 173
CI - Costa d'Avorio 153
TG - Togo 136
EE - Estonia 84
ZA - Sudafrica 79
CH - Svizzera 69
BG - Bulgaria 63
FI - Finlandia 61
NG - Nigeria 43
JO - Giordania 41
IR - Iran 22
BE - Belgio 20
CA - Canada 20
NL - Olanda 19
SC - Seychelles 15
ES - Italia 12
BR - Brasile 10
RO - Romania 10
JP - Giappone 9
AT - Austria 8
MK - Macedonia 8
UZ - Uzbekistan 8
ID - Indonesia 7
PH - Filippine 7
GR - Grecia 6
HR - Croazia 6
PK - Pakistan 6
AU - Australia 5
LB - Libano 5
PL - Polonia 5
DK - Danimarca 4
PT - Portogallo 4
TR - Turchia 4
CZ - Repubblica Ceca 3
EU - Europa 3
HK - Hong Kong 3
KR - Corea 3
NO - Norvegia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
EG - Egitto 2
IL - Israele 2
LK - Sri Lanka 2
MM - Myanmar 2
DZ - Algeria 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PE - Perù 1
TH - Thailandia 1
Totale 13.404
Città #
Southend 1.001
Chandler 770
Fairfield 751
Singapore 558
Ashburn 453
Dong Ket 361
Woodbridge 359
Wilmington 355
Houston 283
Seattle 281
Santa Clara 280
Princeton 274
Cambridge 235
Ann Arbor 216
Dublin 216
Jacksonville 155
Boardman 154
Abidjan 152
Lomé 136
Nanjing 106
Westminster 103
Bologna 95
Padova 93
Berlin 82
Saint Petersburg 63
Helsinki 60
Sofia 60
Jinan 58
Bern 57
Florence 54
Milan 48
Shenyang 48
Redmond 46
Abeokuta 43
New York 43
Amman 41
San Diego 40
Dearborn 39
Turin 38
Hebei 36
Beijing 33
Nanchang 33
Medford 32
Des Moines 31
Los Angeles 28
Tianjin 28
Mülheim 27
Bremen 26
Guangzhou 26
Jiaxing 25
Rome 24
Redwood City 21
Zhengzhou 21
Brussels 20
Olalla 19
Changsha 18
Haikou 17
Hangzhou 17
Norwalk 17
Hyderabad 16
Ningbo 16
Falkenstein 15
Mahé 15
Shanghai 14
Lanzhou 13
Mountain View 13
Phoenix 13
Potenza 13
Bühl 12
Falls Church 12
London 12
Monmouth Junction 11
Paris 11
Portland 11
Taiyuan 11
Taizhou 11
Leawood 10
Pune 9
Toronto 9
Verona 9
Madrid 8
Nottingham 8
San Francisco 8
Tokyo 8
Chengdu 7
Jakarta 7
Ottawa 7
Shenzhen 7
Shijiazhuang 7
Wuhan 7
Zanjan 7
Amsterdam 6
Buffalo 6
Cesena 6
Encino 6
Frankfurt Am Main 6
Fuzhou 6
Genoa 6
Harbin 6
Hefei 6
Totale 9.097
Nome #
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 224
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 216
A comprehensive analysis on expected years of life lost due to pancreatic cancer 203
A new liver transplant priority for patients with hepatocellular carcinoma. 187
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 186
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 181
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 170
Combined liver–dual kidney transplant: Role in expanded donors 170
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 166
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 163
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 160
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 159
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 159
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 153
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 151
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 147
Coping strategies in intestinal transplantation 147
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 144
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 141
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 141
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 140
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 139
Efficacy of MELD score in predicting survival after liver retransplantation. 138
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 137
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 137
Using Elderly Donors in Liver Transplantation. 136
null 135
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 134
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 134
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 133
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 133
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 132
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 131
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 126
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. 125
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 123
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. 122
Kidney preservation: review of present and future perspective. 121
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 120
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 119
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 118
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 118
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 118
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 118
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 116
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 115
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 115
The role of liver resections for metastases from lung carcinoma. 114
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 114
Liver tissue: a proof-of-concept study for OLT in MNGIE patients 113
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 113
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. 112
Long-term results after curative resection for carcinoma of the gallbladder according to the TNM stage 110
Liver Transplantation With Left Lateral Segments in Adults: A Risk or a Possibility? 110
Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. 110
Surgical therapy for hepatolithiasis: a Western experience. 110
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 109
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 108
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 106
Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. 105
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 105
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 105
Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? 103
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. 103
Surgical approach to complicated intestinal failure for benign disease in adult patients: transplantation or surgical rehabilitation? 103
The role of liver resections for metastases from lung carcinoma 102
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience. 102
Sirolimus in liver transplant recipients: a large single-center experience. 102
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 101
Medication compliance after liver transplantation: the importance of family support 100
Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years. 100
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. 99
Radical surgery for gallbladder carcinoma: possibilities of survival 99
The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. 97
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 95
The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. 94
Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human Kidneys 94
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE. 94
Prospective down-staging protocol for HCC not meeting the Milan criteria 94
Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. 93
Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. 93
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 93
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 93
Qualità di vita e benessere psicologico nel trapianto d'intestino 91
Liver transplantation with the Meld system: a prospective study from a single European center. 90
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor. 90
Liver and Vena Cava En Bloc Resection for an Invasive Leiomyosarcoma Causing Budd-Chiari Syndrome, Under Veno-Venous Bypass and Liver Hypothermic Perfusion : Liver Hypothermic Perfusion and Veno-Venous Bypass for Inferior Vena Cava Leiomyosarcoma 89
Reply 88
MATCH DONATORE-RICEVENTE NEL TRAPIANTO DI FEGATO: COME MIGLIORARE LA SOPRAVVIVENZA NEI PAZIENTI CON MELD ELEVATO NELL'ERA DEI DONATORI MARGINALI 87
HCV ED ETA' AVANZATA SONO LIMITI SUPERABILI NELLA DONAZIONE DI RENE DA VIVENTE 86
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for cholangiocarcinoma 85
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 84
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 84
Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study 84
Double common bile duct: a pitfall during liver transplantation and cholecystectomy. 82
Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients 80
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis 79
Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience 78
DOPPI TRAPIANTI DI RENE MONOLATERALI CON RICOSTRUZIONI VASCOLARI A BANCO IN GRFAFT CON VASI MULTIPLI E RICEVENTI SEVERAMENTE ATEROMASICI 78
DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC 78
Totale 11.932
Categoria #
all - tutte 37.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.805 0 0 0 0 0 299 342 343 409 174 96 142
2020/20211.786 304 119 35 79 34 81 22 93 176 132 109 602
2021/20222.357 174 97 123 200 224 106 57 187 81 158 539 411
2022/20233.190 293 501 163 408 202 253 119 199 600 93 234 125
2023/2024814 75 164 57 78 58 137 41 42 16 59 41 46
2024/20251.813 177 468 272 296 447 153 0 0 0 0 0 0
Totale 13.705